| Literature DB >> 25140477 |
Anne Kastelianne França da Silva1, Marianne Penachini da Costa de Rezende Barbosa1, Aline Fernanda Barbosa Bernardo1, Franciele Marques Vanderlei1, Francis Lopes Pacagnelli2, Luiz Carlos Marques Vanderlei1.
Abstract
OBJECTIVE: Gather and describe general characteristics of different protocols of risk stratification for cardiac patients undergoing exercise.Entities:
Mesh:
Year: 2014 PMID: 25140477 PMCID: PMC4389445 DOI: 10.5935/1678-9741.20140067
Source DB: PubMed Journal: Rev Bras Cir Cardiovasc
General characteristics of the methods of risk stratification.
| Protocol | General Characteristics | Classification |
|---|---|---|
| ACSM (2007) | Targeted at any individual who wants to perform an exercise program. Uses the presence of risk factors, signs and symptoms of cardiovascular, metabolic, and respiratory diseases as risk selection criteria. it does not discuss results of additional tests for stratification. | Low, moderate and High Risk. |
| SBC (2013) | Targeted at those who have suffered AMI and it uses the maximal exercise test as a primary method of risk stratification. It also uses the presence of signs and symptoms of congestive heart failure in high-risk individuals. It considers as high risk those individuals with functional capacity = 5 METs and EF = 35%. | Low, moderate and High Risk. |
| AHA (2001) | Extensive method that uses mainly symptoms or the presence of heart disease, risk factors, and exercise testing for risk selection. It considers as high risk those individuals with functional capacity <6 METs and EF ≤ 30%. | Risk Classes (A, B, C and D). |
| PASHKOW (1993) | Targeted at those who have suffered AMI. It uses results of complementary tests to stratify risk. It considers as high risk for events those individuals with functional capacity ≤ 4.5 METs. It does not use EF as criteria. | Low, moderate and High Risk. |
| AACVPR (2007) | It uses the maximal exercise test as the primary method of risk stratification (presence of symptoms during stress or recovery test). Their absence may inappropriately categorize the individual. Targeted at those who have suffered AMI. It considers as high risk those individuals with functional capacity <5 METs and EF <40%. | Low, moderate and High Risk. |
| SFC (2002) | Targeted at those who have suffered AMI based mainly on clinical history and maximal exercise test. It considers at high-risk individuals with functional capacity <5 METs and EF <30%. | Low, moderate and High Risk. |
| SEC (2000) | Designed for individuals who have suffered AMI. It uses clinical data and tests such as echocardiography and exercise testing to define risk groups. It considers as high risk those individuals with functional capacity <5 METs and EF <35%. | Low, moderate and High Risk. |
| SEC (2000) | Designed for individuals who have suffered AMI and wish to participate in sports activities. It evaluates VO2max associated with age to designate METs value in low-risk individuals. It considers as high risk those individuals with EF <50%. | Low and High Risk. |
SBC: Brazilian Society of Cardiology; ACSM: American College of Sports Medicine; AHA: American Heart Association; AACVPR: American Association of Cardiovascular and Pulmonary Rehabilitation; SFC: French Society of Cardiology; SEC: Spanish Society of Cardiology; METs: Metabolic Equivalent; EF: Ejection Fraction; CHF: Congestive Heart Failure; AMI : Acute Myocardial Infarction; VO2 Max: Maximum Oxygen Consumption
ACSM criteria for risk stratification of events during the year.
| Low Risk | |
| • | Men under 45 years of age and women under age 55 who are asymptomatic and do not meet more than a threshold of major risk (Positive factors - family history, cigarette smoking, hypertension, hypercholesterolemia, impaired fasting glucose, obesity, sedentary lifestyle. Negative factors - high serum HDL cholesterol). |
| Moderate Risk | |
| • | Men aged 45 years or older, women aged 55 or more; or those who satisfy the threshold for two or more major risk factors described above. |
| High Risk | |
| • | Individuals with one or more signs and symptoms (pain; discomfort in the chest, neck, jaw or arms; breathlessness at rest or on rapid exertion; dizziness or syncope, orthopnea or paroxysmal nocturnal dyspnea; edema of the ankles, palpitations or tachycardia intermittent claudication; known heart murmur; excessive fatigue; breathlessness in daily activities) or cardiovascular disease (heart disease, cerebrovascular, peripheral vascular), lung disease (chronic obstructive pulmonary disease, asthma, interstitial lung disease, cystic fibrosis) or known metabolic disease (diabetes mellitus, thyroid disorders, kidney or liver disease). |
SBC criteria for risk stratification of events during the year.
| Low Risk | |
| • | Functional Capacity = 7 METs. |
| • | Absence of myocardial ischemia at rest or stress test with less than 6 METs intensity. |
| • | Left ventricular EF = 50%. |
| • | Absence of significant ventricular ectopy after the third day after AMI. |
| • | Adequate blood pressure response to stress. |
| • | Ability to self-monitor the intensity with which one exercises |
| Moderate Risk | |
| • | Presence of myocardial ischemia. |
| • | ST depression = 2 mm segment. |
| • | Reversible abnormalities during exercise, myocardial scintigraphy with thallium. |
| • | Left ventricular EF = 35-49%. |
| • | Absence of complex ventricular ectopy. |
| • | No drop in blood pressure during exercise. |
| High Risk | |
| • | Recurring angina with ischemic changes in ST segment beyond 24 hours after hospital admission. |
| • | Signs and symptoms of congestive heart failure. |
| • | Left ventricular EF = 35%. |
| • | Complex ventricular ectopy (multifocal premature ventricular contractions, ventricular tachycardia, R on T phenomenon, ventricular fibrillation). |
| • | Functional Capacity = 5 METs in angina limited exertion test, ST segment depression or inadequate blood pressure response. |
| • | Decreased or failure to increase systolic blood pressure during exercise. |
| • | Persistent ischemic changes in ST and/or angina during exercise. |
METs: metabolic equivalent; EF: ejection fraction; AMI: Acute Myocardial Infarction
AHA criteria for risk stratification of events during exercise in healthy individuals (class A) and low risk (class B).
| Class A | |
| This classification includes: | |
| • | A1: Children, adolescents, men < 45 years old, and women < 55 years old who have no symptoms or known presence of heart disease or major coronary risk factors. |
| • | A2: Men ≥ 45 years old and women ≥ 55 years old who have no symptoms or known presence of heart disease and with < 2 major cardiovascular risk factors. |
| • | A3: Men ≥ 45 years old and women ≥ 55 years old who have no symptoms or known presence of heart disease and with ≥ 2 major cardiovascular risk factors. |
| Class B | |
| This classification includes individuals with any of the following diagnoses: | |
| • | B1: CAD (MI, CABG, PTCA, angina pectoris, abnormal exercise test, and abnormal coronary angiograms) whose condition is stable and who have the clinical characteristics outlined below. |
| • | B2: Valvular heart disease, excluding severe valvular stenosis or regurgitation with the clinical characteristics outlined below. |
| • | B3: Congenital heart disease; risk stratification for patients with congenital heart disease should be guided by the 27th Bethesda Conference recommendations*. |
| • | B4: Cardiomyopathy: EF < 30%; includes stable patients with heart failure with clinical characteristics as outlined below, excluding hypertrophic cardiomyopathy or recent myocarditis. B5: Exercise test abnormalities that do not meet any of the high risk criteria outlined in class C below. |
| Clinical characteristics (must include all of the following) | |
| Clinical characteristics according to additional tests. They should check all the clinical features present. | |
| 1. | New York Heart Association class 1 or 2 |
| 2. | Exercise capacity ≤ 6 METs |
| 3. | No evidence of congestive heart failure |
| 4. | No evidence of myocardial ischemia or angina at rest or on the exercise test at or below 6 METs |
| 5. | Appropriate rise in systolic blood pressure during exercise |
| 6. | Absence of sustained or nonsustained ventricular tachycardia at rest or with exercise |
| 7. | Ability to satisfactorily self-monitor intensity of activity |
| *Fuster V, Gotto AM, Libby P. 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for coronary disease events. J Am Coll Cardiol 1996;27:964-76. | |
EF: ejection fraction; CAD: Coronary Artery Disease; MI: Myocardial Infarction; CABG: coronary artery bypass graft; PTCA: Percutaneous Transluminal Coronary; METs: Metabolic Equivalent
AHA criteria for risk stratification of events during exercise in individuals with moderate to high risk (class C) and activity restriction (class D).
| Class C | |
| This classification includes individuals with any of the following diagnoses: | |
| • | C1: CAD with the clinical characteristics outlined below. |
| • | C2: Valvular heart disease, excluding severe valvular stenosis or regurgitation with the clinical characteristics outlined below. |
| • | C3: Congenital heart disease; risk stratification for patients with congenital heart disease should be guided by the 27th Bethesda Conference recommendations*. |
| • | C4: Cardiomyopathy: EF 30%; includes stable patients with heart failure with the clinical characteristics outlined below, excluding hypertrophic cardiomyopathy or recent myocarditis. |
| • | C5: Complex ventricular arrhythmias not well controlled. |
| Clinical characteristics (any of the following): | |
| 1. NYHA class 3 or 4. | |
| 2. Exercise test results | |
| • | Exercise capacity 6 of METs |
| • | Angina or ischemic ST depression at a workload of 6 METs |
| • | Fall in systolic blood pressure below resting levels during exercise |
| • | Nonsustained ventricular tachycardia with exercise |
| 3. Previous episode of primary cardiac arrest (ie, cardiac arrest that did not occur in the presence of an acute myocardial infarction or during a cardiac procedure). | |
| 4. A medical problem that the physician believes may be life- threatening. | |
| Class D | |
| This classification includes individuals with any of the following: | |
| • | D1: Unstable ischemia. |
| • | D2: Severe and symptomatic valvular stenosis or regurgitation. |
| • | D3: Congenital heart disease; criteria for risk that would prohibit exercise conditioning in patients with congenital heart disease should be guided by the 27th Bethesda Conference recommendations*. |
| • | D4: Heart failure that is not compensated. |
| • | D5: Uncontrolled arrhythmias. |
| • | D6: Other medical conditions that could be aggravated by exercise. |
| *Fuster V, Gotto AM, Libby P, Loscalzo J, McGill HC. 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for coronary disease events. J Am Coll Cardiol 1996;27(5):964-76. | |
CAD: Coronary Artery Disease; EF: Ejection Fraction; NYHA: New York Heart Association; METs: Metabolic Equivalent
Criteria defined by Pashkow for risk stratification of events during the year.
| Low Risk | |
| • | After uncomplicated coronary revascularization |
| • | ≥ 7.5 METs 3 weeks after an ischemic event |
| • | No ischemia, left ventricular dysfunction or significant arrhythmia |
| Moderate Risk | |
| • | ≤ 7.5 METs 3 weeks after an ischemic event |
| • | Angina or 1 - to 2- mm ST segment depression with exercise |
| • | Perfusion or wall motion abnormalities with stress |
| • | History of congestive heart failure |
| • | More than mild but less than severe left ventricular dysfunction |
| • | Late potentials present on signal-averaged electrocardiogram |
| • | Nonsustained venricular arrhythmia |
| • | Inability to self-monitor exercise or comply with exercise prescription |
| High Risk | |
| • | Severe left ventricular dysfunction |
| • | ≤ 4.5 METs 3 weeks after cardiac event |
| • | Exercise-induced hypotension (≥ 15 mmHg) |
| • | Exercise-induced ischemia > 2-mm ST segment depression |
| • | Ischemia induced at lows levels of exercise |
| • | Persistence of ischemia after exercise |
| • | Sustained ventricular arrhythmia spontaneous or induced |
METs: Metabolic Equivalent
AACVPR criteria for risk stratification in patients with low, moderate and high risk of events during the year.
| Low Risk | |
| • | Absence of complex ventricular dysrhythmia during exercise testing and recovery |
| • | Absence of angina or other significant symptoms (e.g., unusual shortness of breath, light-headedness, or dizziness heart rate and systolic blood pressure with increasing workloads and recovery) |
| • | Presence of normal hemodynamics during exercise testing and recovery (i.e., appropriate increases and decreases in heart rate and systolic blood pressure with increasing workloads and recovery) |
| • | Functional capacity ≥ 7 METs |
| Nonexercise testing findings | |
| • | EF ≥ 50% at rest |
| • | Uncomplicated MI or revascularization procedure |
| • | Absence of complicated ventricular arrhythmias at rest |
| • | Absence of CHF |
| • | Absence of signs or symptoms of post-event or post-procedure ischemia |
| • | Absence of clinical depression |
| Nonexercise testing findings | |
| • | EF ≥ 50% at rest |
| • | Uncomplicated MI or revascularization procedure |
| • | Absence of complicated ventricular arrhythmias at rest |
| • | Absence of CHF |
| • | Absence of signs or symptoms of post-event or post-procedure ischemia |
| • | Absence of clinical depression |
| Moderate Risk | |
| • | Presence of angina or other significant symptoms (e.g., unusual shortness of breath, light headedness, or dizziness occurring only at high levels of exertion [ <7METs]) |
| • | Mild to moderate level of silent ischemia during exercise testing or recovery (ST-segment depression < 2 mm from baseline) |
| • | Function capacity < 5 METs |
| Nonexercise testing findings: | |
| • | EF = 40% to 49% at rest |
| High Risk | |
| • | Presence of complex ventricular arrhythmias during exercise testing or recovery |
| • | Presence of angina or other significant symptoms (e.g., unusual shortness of breath, light-headedness, or dizziness at low levels of exertion [≥ 5 METs] or during recovery) |
| • | High level of silent ischemia (ST-segment depression ≥ 2 mm from baseline) during exercise testing or recovery |
| • | Presence of abnormal hemodynamics with exercise testing (i.e., chronotropic incompetence or flat or decreasing systolic BP with increasing workloads) or recovery (i.e., severe postexercise hypotension) |
| Nonexercise testing findings: | |
| • | EF < 40% at rest History of cardiac arrest or sudden death Complex dysrhythmias at rest |
| • | Complicated MI or revascularization procedure |
| • | Presence of CHF |
| • | Presence of signs or symptoms of postevent or postprocedure ischemia |
| • | Presence of clinical depression |
METs : Metabolic Equivalent; EF: Ejection Fraction; MI: Myocardial Infarction; CHF: Congestive Heart Failure; BP: Blood Pressure
SFC criteria for risk stratification of events during the year.
| Low Risk | |
| • | Hospital clinical evolution without complications (without recurrent ischemia, heart failure or severe ventricular arrhythmia). |
| • | Good functional capacity (>6 METs) three weeks or more after the acute phase. |
| • | Systolic function of the left ventricle preserved. |
| • | Absence of myocardial ischemia at rest or during exercise. |
| • | Absence of serious ventricular arrhythmias at rest or during exercise. |
| Moderate Risk | |
| • | Moderate functional capacity (5-6 METs) three weeks or more after the acute phase, high ischemic threshold. |
| • | Moderately impaired systolic function of the left ventricle. |
| • | Moderate residual myocardial ischemia and/or depression of the ST <2 mm segment in the stress test or reversible myocardial ischemia during echocardiography or isotopic explorations. |
| • | Mild ventricular arrhythmias (Lown class I or II) at rest or during exercise. |
| High Risk | |
| • | Evolution of hospital clinical complications (heart failure, cardiogenic shock and/or severe ventricular arrhythmia). |
| • | Survivors of sudden death. |
| • | Low functional capacity (<5 METs) three weeks or more after the acute phase. |
| • | Severely impaired left ventricular function (EF <30%). |
| • | Residual myocardial ischemia (severe incapacitating exertion angina, low ischemic threshold and/or ST-segment depression >2 mm on the electrocardiogram in exercise). |
| • | Complex ventricular arrhythmias (Lown Class III, IV, and V) at rest from exercise. |
METs: Metabolic Equivalent; EF: Ejection Fraction
ESC criteria for risk stratification of events during the year to participate in a cardiac rehabilitation program.
| Low Risk | |
| • | Hospital clinical evolution without complications |
| • | Functional capacity >7 METs |
| • | Absence of ischemia |
| • | EF >50% |
| • | Absence of severe ventricular arrhythmias |
| Moderate Risk | |
| • | Occurrence of Angina |
| • | Abnormalities reversible with thallium stress |
| • | Functional capacity between 5-7 METs |
| • | EF 35-49% |
| High Risk | |
| • | Reinfarction. Hospital CHF |
| • | ST segment depression of >2 mm with HR <135 bpm |
| • | Functional capacity <5 METs with or without ST-segment depression |
| • | EF <35% |
| • | Hypotensive response to stress |
| • | Malignant ventricular arrhythmias |
METs: Metabolic Equivalent; EF: Ejection Fraction; CHF: Congestive Heart Failure
ESC criteria for risk stratification of events during the year for participants in sports activities.
| Low Risk | |
| • | Systolic function normal at rest (EF greater than 50%). |
| • | Normal tolerance to exercise. |
| - Patients under 50 years old: greater than 35 ml/min kg (10 METs) VO2max | |
| - Patients between 50 and 59 years old: greater than 31 ml/min kg (9 METs) VO2max | |
| - Patients between 60 and 69 years old: greater than 28 ml/min kg (8 METs) VO2max | |
| - Patients over 70 years old: VO2max greater than 24 ml/min kg (7 METs) | |
| • | Absence of exercise-induced ischemia. |
| • | Absence of exercise-induced arrhythmias. |
| • | Absence of coronary stenosis or greater than 50%, indicating good coronary revascularization. |
| Moderate Risk | |
| Does not mention | |
| High Risk | |
| • | Depressed systolic function at rest (EF less than 50%). |
| • | Evidence of exercise-induced ischemia. |
| • | Evidence of exercise-induced arrhythmias. |
| • | Coronary lesions exceeding 50% stenotis. |
EF: Ejection Fraction; VO2max: Maximum Oxygen Consumption; METs: Metabolic Equivalent
| Abbreviations, acronyms & symbols | |
|---|---|
| AACVPR | American Association of Cardiovascular and Pulmonary Rehabilitation |
| ACSM | American College of Sports Medicine |
| AHA | American Heart Association |
| BSC | Brazilian Society of Cardiology |
| CR | Cardiac rehabilitation |
| CVD | Cardiovascular diseases |
| HRF | Heart rate frequency |
| METs | Metabolic equivalent |
| SFC | Société Française de Cardiologie |
| Authors’ roles & responsibilities | |
|---|---|
| AKFS | Analysis and/or interpretation of data; final approval of the manuscript; conception and design of the study; implementation of operations and/or experiments; writing of the manuscript or revising it critically for content |
| MPCRB | Analysis and/ or interpretation of data; implementation of operations and/or experiments; writing of the manuscript or revising it critically for content |
| AFBB | Analysis and/or interpretation of data; implementation of operations and/or experiments; writing of the manuscript or revising it critically for content |
| FMV | Analysis and/or interpretation of data; conception and design of the study; implementation of operations and/or experiments; writing of the manuscript or revising it critically for content |
| FLP | Analysis and/or interpretation of data; conception and design of the study; implementation of operations and/or experiments; writing of the manuscript or revising it critically for content |
| LCMV | Analysis and/or interpretation of data; final approval of the manuscript; conception and design of the study; implementation of operations and/or experiments; writing of the manuscript or revising it critically for content |